Mercer Global Investment Forums 2019

2019

SYDNEY9 April 2019

BRAVING THE ELEMENTS – SURFING THE LATE CYCLE

As the 10-year anniversary of the Global Financial Crisis came and went, 2018 saw the return of volatility in global asset markets. Trade tensions between the US and China, tightening monetary conditions (led by the US) and signals from both investment markets and the real economy of slowing global growth have resulted in increased uncertainty, equity market corrections and lower investor confidence. We expect 2019 to be a continuation of this move toward a more normal investment environment, with potential for higher interest rates, rising inflation and further volatility spikes. In this environment we see that our clients could benefit from keeping it simple and going back to the basic elements of investing: asset allocation, risk management, operational efficiency and sustainability.

Mercer's "2019 Themes and Opportunities" series highlights the potential of unrewarded risks present in the market and also looks at how global economies and market participants' behavior in the 10 years since the financial crisis have changed and are impacting markets and creating opportunities. We highlight the ever-growing trend toward sustainable investing, which is now becoming standard.

Our Global Investment Forums 2019 will develop these themes alongside general and investor-specific risks inherent in the current investment environment, but also the opportunities that exist to help position portfolios for the short term and into the future.

We look forward to seeing you in Sydney.

Join us and be part of the conversation.


Keynote Speaker

Dr Aubrey de Grey

Chief Science Officer, SENS Research Foundation

Dr Aubrey de Grey is a biomedical gerontologist and the Chief Science Officer of SENS Research Foundation, a California-based 501(c)(3) biomedical research charity that performs and funds laboratory research dedicated to combating the ageing process. Based in Mountain View, California, he is also VP of New Technology Discovery at AgeX Therapeutics, a biotechnology start-up developing new therapies in the field of biomedical gerontology. In addition, he is Editor-in-Chief of Rejuvenation Research, the world's highest-impact peer-reviewed journal focused on intervention in ageing.

READ MORE
Register

2018 Event highlights

Contact Us


For information about the event, please contact Alexis Livesey:

Did you know?

Members of some professional bodies may be able to claim continuing professional development credits for attending this event

© 2018 Mercer LLC, All Rights Reserved.